Browse
Submit Data
Databases
API
Help

Dataset Information

2 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Call for an enzyme genomics initiative.

ABSTRACT: I propose an Enzyme Genomics Initiative, the goal of which is to obtain at least one protein sequence for each enzyme that has previously been characterized biochemically. There are 1,437 enzyme activities for which Enzyme Commission (EC) numbers have been assigned but no sequence can be found in public protein-sequence databases.

SUBMITTER: Karp PD

PROVIDER: S-EPMC507876 | biostudies-other | 2004

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

Call for an enzyme genomics initiative.

Karp Peter D PD

Genome biology 20040730 8

I propose an Enzyme Genomics Initiative, the goal of which is to obtain at least one protein sequence for each enzyme that has previously been characterized biochemically. There are 1,437 enzyme activities for which Enzyme Commission (EC) numbers have been assigned but no sequence can be found in public protein-sequence databases. ...[more]

PMID: 15287973

Similar Datasets

The Enzyme Function Initiative.

Project description: Not available

| S-EPMC3238057 | biostudies-literature

Improvement initiative in LDL-C management in Saudi Arabia: A call to action.

Project description: Not available

| S-EPMC7596183 | biostudies-literature

Broad Institute Viral Genomics Initiative

Project description:Broad Institute Viral Genomics Initiative

| PRJNA32415 | ENA

Gene expression in pediatric cALL

Project description:Common ALL (cALL) is the most frequent entity of childhood ALL and carries an early pre-B cell phenotype. Expression patterns of 25 pediatric cALL samples were analyzed by use of high-density DNA microarrays HG-U133A. Leukemic patients’ bone marrow samples were compared to sorted B cells from cord blood of healthy donors expressing CD19 and CD10 surface antigens. Differential gene expression profiling of pediatric cALL versus non-malignant tissues enabled the identification of aberrantly expressed genes in malignant cells, facilitating discrimination of leukemic from normal cells and possibly revealing specific disease mechanisms. Principal component analysis clearly distinguished leukemia samples from normal controls. Significance analysis of microarrays revealed 487 genes significantly up-regulated, and 572 down-regulated genes in leukemic cells. A comparison to previous publications investigating genetically defined subsets of cALL revealed 465 genes previously not associated with cALL. Interestingly, terminal deoxynucleotidyl-transferase (DNTT) as well as in the context of cALL unknown genes, were found to be the strongest predictive genes for the malignant phenotype signifying the diagnostic value of our approach.

2012-06-30 | GSE34670 | GEO

Comparative modeling and genomics for galactokinase (Gal1p) enzyme.

Project description: Not available

| S-EPMC3055162 | biostudies-literature

Dystrophia Myotonica Biomarker Discovery Initiative

Project description:As part of the Dystrophia Myotonica Biomarker Discovery Initiative (DMBDI) a dataset was obtained from 35 participants, including 31 Myotonic Dystrophy type 1 (DM1) cases and four unaffected controls. All DM1 cases in this research were heterozygous for the abnormally expanded CTG repeat. The mode of the length of the DM1 CTG expansion (Modal Allele Length, MAL) was determined by small-pool PCR of blood DNA for 35/36 patients. For this work we did not attempt to measure the repeat length from muscle, due to a very high degree of repeat instability in muscle cells, and associated difficulties in its experimental measurement. One patient refused blood donation. For each of the 35 blood-donating patients mRNA expression profiling of blood was performed using Affymetrix GeneChip™ Human Exon 1.0 ST microarray. For 28 of 36 patients a successful quadriceps muscle biopsy was obtained. The muscle tissue was mRNA profiled using the same type of microarray. In total, a complete set of samples (blood and muscle) was obtained for 27 of 36 patients; samples were given a disease staging score based on muscle impairment rating. mRNA profiling was carried out by the GeneLogic service lab (on a fee-for-service basis) using standard Affymetrix hybridisation protocol.

2019-05-31 | E-MTAB-7983 | biostudies-arrayexpress

Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks.

Project description: Not available

| S-EPMC4457552 | biostudies-literature

Structure modeling and comparative genomics for epimerase enzyme (Gal10p).

Project description: Not available

| S-EPMC3055706 | biostudies-literature

Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative.

Project description: Not available

| S-EPMC8026392 | biostudies-literature

Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice.

Project description: Not available